All News
ACR21 Previews from Creaky Joints
CreakyJoints will present 11 posters and two oral presentations at ACR 2021. COVID-19 research revealed significantly high levels of anxiety, anger, depression, and social isolation, which were linked to medication interruptions and associated flares suggesting during the pandemic, patients often felt unsupported by all levels of the healthcare system.
Read Article
Industry Press Releases - BMS, Abbvie, UCB, Janssen
The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at ACR Convergence 2021. Below is a listing of some of their best studies for you to review and look for in the meeting.
Read Article
There is a lot of talk about #COVID19 vaccines, however we don't much about existing vaccines (eg flu) in our patients! Much more work to be done here in rheumatology! @DrDavidKarp at #ACR21 opening session @rheumnow
Bella Mehta bella_mehta ( View Tweet)
@DoctorYasmin: "Let's talk about the history ... let's build bridges." We individualize approach to treatments, we should also individualize our conversation about vaccine hesitancy to your patient's specific concerns. @rheumnow #ACR21 https://t.co/1Jxw8l2phB
Eric Dein ericdeinmd ( View Tweet)
@DoctorYasmin @RheumNow Great discussion #ACR21 @DoctorYasmin: how do we stop panic/misinformation during a pandemic?
To improve health literacy, we need to learn how to engage better:
- understand the issues/public thinking
- targeted messaging to different communities
- avoid medical hubris
@RheumNow https://t.co/FLvPvX3UJc
David Liew drdavidliew ( View Tweet)
@DrDavidKarp: "We are learning about #COVID19 vaccine, but we don't know what to do about the other vaccines." Its a great opportunity for us to learn, research, and educate about the flu, shingles, pneumonia, and more vaccines. 💉 @RheumNow #ACR21
Eric Dein ericdeinmd ( View Tweet)
"I am often asked when are we going back to normal? NO! I don't want to go back to Normal....we need systems that are more resilient" @DoctorYasmin on lessons learned from #COVID to prepare for future challenges/outbreaks #ACR21 @RheumNow https://t.co/DAdCH80uQ5
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
@DoctorYasmin notes that anti-vaccination is not a new phenomenon & that we cannot adopt a "one size fits all" method in tackling vaccine hesitancy. She emphasizes the need for targeted messaging & the ideology that vaccination is anti-American must be debunked! #ACR21 @RheumNow https://t.co/cU33XEOYhM
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
"If we go back to business as usual, we will have failed." @DoctorYasmin in the #ACR21 Opening Session.
We need systems that don't need a crisis to shine on them to progressively change for the better. @RheumNow https://t.co/uf4OO2VpHV
David Liew drdavidliew ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @Novartis. All content chosen by #RheumNow & its Faculty.
Dr. John Cush RheumNow ( View Tweet)
So excited to cover the annual #ACR21 Convergence Conference aside the amazing @Rheumnow Faculty team. A hearty congratulations to our wonderful leader, Dr. Jack Cush @RheumNowNews, for the well-earned designation as an ACR Master. https://t.co/v6fAyqH1CU
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Congratulations to all the ACR Masters announced in the #ACR21 Opening Session, particularly @RheumNow's Jack Cush.
It's been such a privilege learning from you. Amongst all you've done, thank you for opening up the global rheumatology discussion like never before. True impact! https://t.co/MMh8owLfY6
David Liew drdavidliew ( View Tweet)
Intensive RA Rx in the TITRATE study showed Disease activity & less remission in in obese patients, but Anxiety, depression and health perceptions were associated with higher pain and fatigue scores. These are unaccounted for in Rx strategies https://t.co/B8izEjfz8P
Links:
Dr. John Cush RheumNow ( View Tweet)
How I Treat Rheumatoid Arthritis
My Stepwise Approach to DMARD, Biologic and Targeted Synthetic Use in RA patients
QD Clinic is sponsored by https://t.co/V10S4oVFsv's coverage of #ACR21 (November 5-9, 2021)
https://t.co/jizbQ0Bgxq https://t.co/fXLheKv5dw
Dr. John Cush RheumNow ( View Tweet)
Treat-to-Target Works in Gout With No Cardiac Toxicity
New research presented this week at ACR Convergence shows that allopurinol and febuxostat may effectively lower urate levels when used in a treat-to-target approach. #ARC21
Read more...
https://t.co/r2usSxNnfZ https://t.co/GIgAP3T2hd
Links:
Dr. John Cush RheumNow ( View Tweet)
Industry Abstract Previews #ACR21 - Horizon, Aurinia, AstraZeneca Save
The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at ACR Convergence 2021.
https://t.co/ePZHXG5iih https://t.co/xxecyJzwkK
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 Annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush RheumNow ( View Tweet)
Negative Concerns of Telemedicine in Rheumatology
Post-pandemic structured surveys and interviews with rheum patients suggests they may prefer for face-to-face consultations, as telehealth visits run the risk of diagnostic inaccuracies & safety concerns.
https://t.co/FBZ2B1U6Ad https://t.co/1tX35jV76I
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 Annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush RheumNow ( View Tweet)
Pre-ACR is always a good time for a bit of a breath, so we can actually see the forest for the trees #ACR21 @RheumNow https://t.co/lKQF5GziyP
David Liew drdavidliew ( View Tweet)